| Literature DB >> 31921944 |
Foteini Christidi1, Efstratios Karavasilis2, Michail Rentzos1, Georgios Velonakis2, Vasiliki Zouvelou1, Sofia Xirou1, Georgios Argyropoulos2, Ioannis Papatriantafyllou3, Varvara Pantolewn2, Panagiotis Ferentinos4, Nikolaos Kelekis2, Ioannis Seimenis5, Ioannis Evdokimidis1, Peter Bede6,7,8.
Abstract
A prospective, standardised neuroimaging protocol was implemented to characterise mesial temporal lobe pathology in amyotrophic lateral sclerosis, Alzheimer's disease and healthy controls focusing on the evaluation of interconnected white and grey matter structures. "Hippocampal pathology in Amyotrophic Lateral Sclerosis: selective vulnerability of subfields and their associated projections" [1]. High-resolution diffusion tensor and structural imaging data were acquired on a 3 T MRI platform using standardised sequence parameters. The integrity of the fornix and the perforant pathway was assessed by tractography, to provide fractional anisotropy, axial diffusivity and radial diffusivity measures. Quantitative structural imaging was used to estimate the total intracranial volume, total hippocampal volumes and hippocampal subfield volumes for each participant. Raw white- and grey-matter measures, demographic and clinical data are available online at 'Mendeley Data'. Amyotrophic lateral sclerosis and Alzheimer's disease exhibit divergent hippocampal profiles.Entities:
Keywords: Alzheimer's disease; Amyotrophic lateral sclerosis; Healthy aging; Hippocampus; MRI; Mesial temporal lobe; Neuroimaging; Tractography
Year: 2019 PMID: 31921944 PMCID: PMC6948121 DOI: 10.1016/j.dib.2019.104991
Source DB: PubMed Journal: Data Brief ISSN: 2352-3409
Fig. 1Memory performance of ALS patients expressed in z-scores. RAVLT–TL = Rey Auditory Verbal Learning Test-Total Learning; RAVLT-IR = Rey Auditory Verbal Learning Test-Immediate Recall; RAVLT-DR = Rey Auditory Verbal Learning Test-Delayed Recall; BSRT-IR = Babcock Story Recall Test-Immediate Recall; BSRT-DR = Babcock Story Recall Test-Delayed Recall; ROCFT-IR = Rey-Osterreith Complex Figure Test-Immediate Recall. Standardized z-scores were calculated based on demographic-adjusted normative data. The horizontal red-dot line highlights the cut-off value (z = −1.67 or 5th percentile) for impaired performance on each measure. Error bars correspond to mean and 95% confidence interval.
Fig. 2The volumetric profile of the left hippocampus in HC, ALS and AD groups. HC = healthy controls; ALS = Amyotrophic Lateral Sclerosis; AD = Alzheimer Disease; L = left; CA = Cornu Ammonis; GC-DG = granule cell layer of dentate gyrus; HATA = hippocampus-amygdala transition area.
Fig. 3The volumetric profile of the right hippocampus in HC, ALS and AD groups. HC = healthy controls; ALS = Amyotrophic Lateral Sclerosis; AD = Alzheimer Disease; L = left; CA = Cornu Ammonis; GC-DG = granule cell layer of dentate gyrus; HATA = hippocampus-amygdala transition area.
Fig. 4The diffusivity profile (FA, Dax, Drad) of the left and right perforant pathway and fornix in HC, ALS and AD. HC = healthy controls; ALS = Amyotrophic Lateral Sclerosis; AD = Alzheimer Disease; L = left; R = right; DTI = diffusion tensor imaging; FA = fractional anisotropy; Dax = axial diffusivity; Drad = radial diffusivity; PPZ = perforant pathway zone.
Fig. 5Effect size differences between HC, ALS and AD that reflect the magnitude of the group differences on DTI metrics for PPZ and Fornix based on estimated marginal means adjusted for age, gender and education. HC = healthy controls; ALS = Amyotrophic Lateral Sclerosis; AD = Alzheimer Disease; L = left; R = right; DTI = diffusion tensor imaging; FA = fractional anisotropy; Dax = axial diffusivity; Drad = radial diffusivity; PPZ = perforant pathway zone. Cohen's |d|>0.80 indicates a large effect size; 0.50–0.79 indicates a moderate effect size; and 0.20–0.49indicates a small effect size.
Included measures.
| Data categories | Specific measures |
|---|---|
| Demographic variables | Age |
| Gender | |
| Years of education | |
| Clinical data for ALS | Disease duration |
| ALSFRS-R | |
| Clinical data for AD | Disease duration |
| Cognitive measures for all participants | MMSE |
| Cognitive measures for ALS patients | RAVLT (Total words recalled across five learning trials) |
| RAVLT (Words recalled in the immediate recall trial) | |
| RAVLT (Words recalled in the delayed recall trial) | |
| BSRT (Immediate recall score) | |
| BSRT (Delayed recall score) | |
| ROCFT (Immediate recall score) | |
| Grey matter volumes | Total hippocampus (R/L) |
| CA1 (R/L) | |
| CA2/CA3 (R/L) | |
| CA4 (R/L) | |
| Fimbria (R/L) | |
| Hippocampal fissure (R/L) | |
| Presubiculum (R/L) | |
| Subiculum (R/L) | |
| Parasubiculum (R/L) | |
| Molecular layer (R/L) | |
| GC-DG (R/L) | |
| HATA (R/L) | |
| White matter tractography (FA) | Hippocampal PPZ (R/L) |
| Fornix | |
| White matter tractography (Dax) | Hippocampal PPZ (R/L) |
| Fornix | |
| White matter tractography (Drad) | Hippocampal PPZ (R/L) |
| Fornix |
Notes. ALS = amyotrophic lateral sclerosis; AD = Alzheimer's disease; ALSFRS-R = amyotrophic lateral sclerosis functional rating scale-revised; MMSE = mini-mental state examination; RAVLT = Rey Auditory Verbal Learning Test; BSRT = Babcock Story Recall Test; ROCFT = Rey Osterreith Complex Figure Test; R/L = right/left; CA = Cornu Ammonis; GC-DG = granule cell layer of dentate gyrus; HATA = hippocampus-amygdala transition area; FA = fractional anisotropy; Dax = axial diffusivity; Drad = radial diffusivity; PPZ = perforant pathway zone.
Specifications Table
| Subject | Radiology, Neuroimaging, Amyotrophic Lateral Sclerosis |
| Specific subject area | MRI, Grey matter volumetry, White matter tractography, Hippocampus, Mesial Temporal Lobe |
| Type of data | Tables |
| How data were acquired | Imaging data were acquired on a Philips Achieva 3T MRI scanner (Philips Medical Systems, Best, The Netherlands) with a 8-channel head coil. |
| Data format | Demographic, raw volumetric and tract-wise diffusivity data for each participant, neuropsychological data for amyotrophic lateral sclerosis patients |
| Parameters for data collection | |
| Description of data collection | Data were collected as part of a cross-sectional prospective research protocol following ethics approval from the local institutional ethics committee. Patients were diagnosed in accordance with current diagnostic criteria and provided written informed consent. Patients with amyotrophic lateral sclerosis underwent standardised neuropsychological evaluation. MRI data were acquired with standardised pulse sequences, anonymised and stored on institutional servers. |
| Data source location | Institution: Aeginition Hospital, Medical School, National and Kapodistrian University of Athens & Medical Center of Athens, Memory Disorders Clinic and Day Care Center for 3rd Age 'IASIS' (clinical data collection) |
| Data accessibility | Hippocampal subfield volumes, tractography metrics, neuropsychological indices and basic demographic variables have been uploaded to ‘Mendeley Data’ |
| Related research article | Authors: Foteini Christidi, Efstratios Karavasilis, Michail Rentzos, Georgios Velonakis, Vasiliki Zouvelou, Sofia Xirou, Georgios Argyropoulos, Ioannis Papatriantafyllou, Varvara Pantolewn, Panagiotis Ferentinos, Nikolaos Kelekis, Ioannis Seimenis, Ioannis Evdokimidis, Peter Bede |
The majority of imaging data sets in amyotrophic lateral sclerosis focus on motor cortex and corticospinal tract integrity Raw volumetric hippocampal data in amyotrophic lateral sclerosis confirm selective subfield involvement Imaging data from amyotrophic lateral sclerosis and Alzheimer's disease reveal divergent mesial temporal lobe profiles Multimodal imaging data confirms the degeneration of interlinked white and grey matter components in ALS Imaging data from amyotrophic lateral sclerosis and disease controls may be used in machine learning applications Quantitative neuroimaging in amyotrophic lateral sclerosis may serve as a non-invasive biomarker of disease burden |